Arterial elasticity reflects the ability of the artery to respond to pressure. The role of arterial elasticity as a marker for a variety of vascular diseases is a subject of increasing study and interest. Dr. Cohn is a leading investigator of arterial elasticity and the emerging understanding of its clinical benefits in the treatment of hypertension. As many as 50 million Americans have hypertension, according to the American Heart Association. Hypertension, commonly known as high blood pressure, occurs when the force of blood against the walls of the arteries is greater than normal.
Hypertension is a major risk factor for coronary heart disease and stroke.
Blocking the production of the angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. Now the mainstay of hypertension therapy in 113 countries, product experience includes well over 73 million patient-months. Tablets is approved by the U.S. Food and Drug Administration. Due to the product's overwhelming success worldwide and increasing demand by U.S. physicians, Solvay Pharmaceuticals has now licensed the drug and will make it available in this country. Tablets will be marketed and distributed nationwide by Solvay Pharmaceuticals, Inc., of Marietta, Ga., a research-based pharmaceuticals company, active in the therapeutic areas of cardiology, women's health, gastroenterology and mental health.